Pharmacokinetics, Safety and Antiviral Activity of Rilpivirine in Antiretroviral-naïve Children With HIV ≥6 to <12 Years Old: Week 48 and Final Analysis of Cohort 2 From the Open-label, Phase 2 PAINT Study
利匹韦林在既往未接受过抗逆转录病毒治疗的 HIV 感染儿童(≥6 岁至 <12 岁)中的药代动力学、安全性和抗病毒活性:开放标签 II 期 PAINT 研究第 2 组队列第 48 周和最终分析
期刊:Pediatric Infectious Disease Journal
影响因子:
doi:10.1097/INF.0000000000004828
Lombaard, Johan; Moolasart, Visal; Lutaakome, Joseph; Van Solingen-Ristea, Rodica; Van Eygen, Veerle; Van Hemelryck, Sandy; Foulkes, Sharne; Natukunda, Eva; Kurosawa, Ken; Shibuya, Minaka; Vanveggel, Simon; Van Landuyt, Erika; Ssali, Francis